Literature DB >> 1388879

Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS.

A Eskild1, P Magnus, G Petersen, C Sohlberg, F Jensen, P Kittelsen, K Skaug.   

Abstract

OBJECTIVE: To study the influence of previous or present hepatitis B virus (HBV) infection on HIV disease progression.
DESIGN: A prospective study of HIV-positive individuals from HIV diagnosis to diagnosis of AIDS or to the end of the follow-up period on 1 January 1991. Mean follow-up time was 62 months.
SETTING: The study population was recruited from a primary health-care clinic for homosexual men and followed by linkage to the National AIDS Registry. PATIENTS, PARTICIPANTS: Of 876 individuals who were tested for HIV, 80 were HIV-positive and included for study. Two individuals were lost to follow-up. MAIN OUTCOME MEASURES: Differences in progression rates to AIDS according to HBV status at study entry.
RESULTS: The adjusted relative risk of progression to AIDS for the 48 subjects who were HBV-antibody-positive at study entry was 3.6 [95% confidence interval (CI), 1.3-10.1]. A high frequency of receptive anal intercourse was also associated with more rapid HIV disease progression; adjusted relative risk 2.6 (95% CI, 1.1-5.9).
CONCLUSIONS: Our results suggest that presence of HBV antibodies is associated with more rapid HIV-disease progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388879     DOI: 10.1097/00002030-199206000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  23 in total

1.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Authors:  Helen M Chun; Mollie P Roediger; Katherine Huppler Hullsiek; Chloe L Thio; Brian K Agan; William P Bradley; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Glenn Wortmann; Nancy F Crum-Cianflone; Jason D Maguire; Michael L Landrum
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone.

Authors:  George A Yendewa; Foday Sahr; Antonio Aguilera; Sulaiman Lakoh; Momodu Sesay; Gibrilla F Deen; Lucia Patiño; Eva Poveda; Robert A Salata
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

Review 3.  Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.

Authors:  Hsin-Yun Sun; Wang-Huei Sheng; Mao-Song Tsai; Kuan-Yeh Lee; Sui-Yuan Chang; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study.

Authors:  D Sène; S Pol; L Piroth; C Goujard; P Dellamonica; J Moussali; D Rey; V Loustaud-Ratti; L Alric; M Chousterman; F Borsa-Lebas; O Boucher; D Séréni; P Cacoub
Journal:  Epidemiol Infect       Date:  2006-07-25       Impact factor: 2.451

Review 5.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

6.  Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

Review 7.  Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.

Authors:  Zhi Q Yao; Jonathan P Moorman
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-12       Impact factor: 4.291

8.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

9.  HIV outcomes in Hepatitis B virus coinfected individuals on HAART.

Authors:  Helen M Chun; Octavio Mesner; Chloe L Thio; Ionut Bebu; Grace Macalino; Brian K Agan; William P Bradley; Jennifer Malia; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Mary Bavaro; Jason D Maguire; Michael L Landrum
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

10.  Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria.

Authors:  Emmanuel Ademola Anigilaje; Ayodotun Olutola
Journal:  ISRN Pediatr       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.